Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Benefits and Pensions Monitor: Trump sets 200% tariff cliff for imported generics by 2029
Merith Basey, chief executive of Patients For Affordable Drugs, warned via Reuters that the measure could backfire for patients, saying tariffs “risk making lower-cost generic drugs millions of Americans rely on more expensive and harder to access.”
News and Reports
Merith Basey, CEO of the advocacy organization Patients for Affordable Drugs, argued that “if the administration intends to lower prescription drug prices, it should not pursue policies that threaten to raise them. Imposing massive tariffs on generic medicines risks making lower-cost generic drugs millions of Americans rely on more expensive and harder to access.” “Generic […]
News and Reports
USA Today: Generic drug tariffs set to skyrocket in 2028. Consumers could feel impact
“Imposing massive tariffs on generic medicines risks making lower-cost generic drugs millions of Americans rely on more expensive and harder to access,” said Merith Basey, CEO of Patients for Affordable Drugs. “Tariffs of this magnitude could have enormous consequences − raising costs, worsening shortages and putting access to lifesaving medicines at risk.”
News and Reports
Reuters: Generic drug sector seeks policy fixes after Trump tariff threat
“Imposing massive tariffs on generic medicines risk making lower-cost generic drugs millions of Americans rely on more expensive and harder to access,” said Merith Basey, CEO of Patients For Affordable Drugs, a patient advocacy organization.
News and Reports
Healthcare Finance: FTC announces settlement with Caremark, resolving PBM lawsuit
Caremark, Express Scripts and OptumRx control roughly 80% of prescriptions filled in the United States, according to Patients for Affordable Drugs. Merith Basey, CEO of Patients for Affordable Drugs, said, “We welcome today’s settlement curbing the power of PBM giants Caremark, Express Scripts and OptumRx who control the vast majority of America’s prescriptions.”
News and Reports
“To build a fairer, more transparent drug market, lawmakers must continue pursuing reforms that hold both drug makers and pharmacy benefit managers accountable for abusive practices that drive up costs for patients — while also working to prevent them in the first place,” said Merith Basey, who heads Patients For Affordable Drugs, an advocacy group, […]
News and Reports
STATEMENT: P4AD Responds to Third FTC Settlement Addressing Big Three PBM Price-Gouging
WASHINGTON, D.C. — With today’s Caremark settlement, the Federal Trade Commission (FTC) has now reached settlements with all three of the nation’s largest Pharmacy Benefit Managers (PBMs), resolving claims that CVS Caremark, Cigna’s Express Scripts, and OptumRx engaged in practices that artificially inflated insulin prices and harmed patients. In response, Merith Basey, CEO of Patients For Affordable […]
News and Reports
Deseret News: When medical needs and financial realities collide
The national organization Patients for Affordable Drugs collects stories from people who struggle with prescription costs in particular. They have a map of the states that link to patient stories. Said the group’s CEO, Merith Basey, “The prescription drug pricing system in the U.S. is rigged against patients, which is why 1 in 3 people […]